Tuam Tshoj-Tebchaws Europe Kev Noj Qab Haus Huv Mixed Fund: Tam sim no Qhov Kev Kho Mob Loj tshaj plaws-Themed Fund hauv Kev Ua Lag Luam

Cov ntaub ntawv qhia tau hais tias thaum kawg ntawm lub quarter thib ob ntawm lub xyoo no, qhov ntsuas ntawm Tuam Tshoj -Europe Healthcare Mixed Fund tau tshaj RMB 31 billion.

Raws li cov ntaub ntawv tshaj tawm nyob rau hauv ib nrab- daim ntawv tshaj tawm txhua xyoo, "cov khoom hnyav hnyav" (cov khoom lag luam nyob qib 11 txog 20th hauv cov peev nyiaj tuav) ntawm Tuam Tshoj-Tebchaws Europe Healthcare Mixed Fund suav nrog Huadong Tshuaj, Haisco Pharmaceutical, Zejing Pharmaceutical, thiab lwm yam.

Ntawm cov khoom hnyav hnyav ranked 11th mus rau 20th, txoj hauj lwm hauv Elpiscience Biopharma tau nce ntau, nce 2,627.32% piv nrog rau xyoo tas los; lub caij no, InnoCare Pharma yog qhov tshiab tshiab ntxiv cov khoom tuav cia.

Los ntawm qhov kev xav ntawm kev lag luam kev faib tawm, cov nyiaj tau txuas ntxiv mus ntxiv nws txoj kev faib mus rau txoj kev lag luam tshuaj tshiab. Qhov tseem ceeb, tus nqi Tshuag ntawm InnoCare Pharma tau nce los ntawm 98.94% hauv thawj ib nrab ntawm lub xyoo, xa cov kev ua tau zoo.

Hais txog qhov kev xav ntawm kev ua lag luam rau ib nrab thib ob, Ge Lan (tus thawj tswj nyiaj txiag) ntseeg tiasKev hloov kho tshiab, kev siv rov qab, thiab kev hloov pauv hauv tsevyuav nyob twj ywm lub hauv paus tsav tsheb ntawm kev lag luam kws tshuaj. Zuag qhia tag nrho, kev lag luam kws tshuaj yuav tswj hwm nws txoj kev loj hlob nyob rau hauv ib nrab thib ob feem ntau yog vam khom rau kev tsim kho tshiab, kev noj qab haus huv, thiab kev hloov pauv hauv tsev.